Cai Jianqiang

[Expert Profile] Cai Jianqiang, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in hepatobiliary surgery in China, working at the Cancer Hospital of the Chinese Academy of Medical Sciences. He has long been dedicated to surgical treatment and comprehensive diagnosis and treatment of liver cancer, colorectal cancer liver metastases, and soft tissue tumors, and is an important leading figure in hepatobiliary oncology surgery in China.

[Education & Career] Professor Cai Jianqiang graduated from a renowned medical university, completed systematic surgical training at the Cancer Hospital of the Chinese Academy of Medical Sciences, and further studied at famous international cancer centers. He has long served as Director of the Department of Hepatobiliary Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, holding important academic positions including Chair of the Liver Cancer Professional Committee of the Chinese Anti-Cancer Association. He has presided over national-level projects including the National Key R&D Program, and is a discipline leader in the field of hepatobiliary oncology surgery in China.

[Areas of Expertise] Professor Cai specializes in precise surgical treatment of liver cancer, conversion therapy and comprehensive treatment of colorectal cancer liver metastases, standardized treatment of soft tissue tumors, and surgical management of complex hepatobiliary and pancreatic tumors. He has profound expertise in minimally invasive and precision surgical techniques such as precise hepatectomy, fluorescent laparoscopy, and combined resection of liver metastases. He excels at developing surgery-centered comprehensive treatment strategies for difficult cases such as "multiple intrahepatic metastases," helping numerous cancer patients achieve radical resection and long-term survival.

[Academic Achievements & Industry Contributions] Professor Cai has led a series of clinical studies on liver cancer and liver metastases, systematically evaluating the effects of different surgical and comprehensive treatment modalities, with findings published in authoritative domestic and international journals. He has participated in the development of Chinese liver cancer diagnosis and treatment guidelines and expert consensus statements, actively promoted the development of standardized liver cancer surgery, minimally invasive techniques, and MDT models, and led multi-center collaborative research and neoadjuvant therapy exploration, significantly improving the overall level of hepatobiliary oncology surgery and patient survival rates in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of hepatobiliary surgery, Professor Cai has led his team in completing tens of thousands of various hepatobiliary tumor surgeries, with surgical technical level ranking among the highest in China. He has successfully treated numerous patients with complex liver cancer and colorectal cancer liver metastases, bringing hope to countless families. He has been repeatedly recognized as an outstanding discipline leader, trained a large number of hepatobiliary surgery professionals, and is deeply trusted by patients and respected by peers alike. He is an outstanding expert in the field of hepatobiliary oncology surgery in China.

[Honors & Reputation] Professor Cai Jianqiang serves as Vice President of the Cancer Hospital of the Chinese Academy of Medical Sciences and Director of the Department of Hepatobiliary Surgery, among other academic positions. He has presided over national-level projects including the National Key R&D Program, and is an authoritative expert in the field of hepatobiliary oncology surgery in China. He has profound expertise in surgical treatment of liver cancer, colorectal cancer liver metastases, and soft tissue tumors. He has led research on precision liver surgery and conversion therapy, promoted standardized application of advanced techniques such as intraoperative ultrasound and 3D visualization, participated in the development of multiple oncology surgery diagnosis and treatment guidelines, and has research findings published in authoritative domestic and international journals. For decades on the clinical front lines, he has helped numerous liver tumor patients gain radical surgical opportunities, and is deeply trusted by patients and respected by peers alike.